Drug Type Biological products |
Synonyms ZYC 200, ZYC200 |
Target |
Action agonists |
Mechanism MC1R agonists(Melanocortin receptor 1 agonists), Immunosuppressants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Asthma | Preclinical | United States | - | |
| Inflammatory Bowel Diseases | Preclinical | United States | - | |
| Multiple Sclerosis | Preclinical | United States | - | |
| Rheumatoid Arthritis | Preclinical | United States | - |





